v3.26.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Sep. 30, 2024 $ 7,155 $ 85,411,771 $ (39,278,587) $ 46,140,339
Balance (in Shares) at Sep. 30, 2024 71,552,402      
Stock-based compensation expense 1,808,478 1,808,478
Net loss (6,659,205) (6,659,205)
Balance at Dec. 31, 2024 $ 7,155 87,220,249 (45,937,792) 41,289,612
Balance (in Shares) at Dec. 31, 2024 71,552,402      
Balance at Sep. 30, 2024 $ 7,155 85,411,771 (39,278,587) 46,140,339
Balance (in Shares) at Sep. 30, 2024 71,552,402      
Net loss         (14,394,757)
Balance at Mar. 31, 2025 $ 7,155 89,308,821 (53,673,344) 35,642,632
Balance (in Shares) at Mar. 31, 2025 71,552,402      
Balance at Dec. 31, 2024 $ 7,155 87,220,249 (45,937,792) 41,289,612
Balance (in Shares) at Dec. 31, 2024 71,552,402      
Stock-based compensation expense 2,088,572 2,088,572
Net loss (7,735,552) (7,735,552)
Balance at Mar. 31, 2025 $ 7,155 89,308,821 (53,673,344) 35,642,632
Balance (in Shares) at Mar. 31, 2025 71,552,402      
Balance at Sep. 30, 2025 $ 8,351 108,897,836 (64,039,956) 44,866,231
Balance (in Shares) at Sep. 30, 2025 83,513,442      
December 2025 sale of common stock and pre-funded warrants, net of costs of $2,872,989 $ 129 15,125,360 15,125,489
December 2025 sale of common stock and pre-funded warrants, net of costs of $2,872,989 (in Shares)   1,284,404      
Stock-based compensation expense 3,956,050 3,956,050
Net loss (5,534,069) (5,534,069)
Balance at Dec. 31, 2025 $ 8,480 127,979,246 (69,574,025) 58,413,701
Balance (in Shares) at Dec. 31, 2025 84,797,846      
Balance at Sep. 30, 2025 $ 8,351 108,897,836 (64,039,956) 44,866,231
Balance (in Shares) at Sep. 30, 2025 83,513,442      
Net loss         (32,143,764)
Balance at Mar. 31, 2026 $ 9,298 131,443,191 (96,183,720) 35,268,769
Balance (in Shares) at Mar. 31, 2026   92,981,204      
Balance at Dec. 31, 2025 $ 8,480 127,979,246 (69,574,025) 58,413,701
Balance (in Shares) at Dec. 31, 2025 84,797,846      
Proceeds from exercise of pre-funded warrants $ 818 $ 818
Proceeds from exercise of pre-funded warrants (in Shares)   8,183,358     8,183,358
December 2025 offering costs (62,765) $ (62,765)
Stock-based compensation expense 3,526,710 3,526,710
Net loss (26,609,695) (26,609,695)
Balance at Mar. 31, 2026 $ 9,298 $ 131,443,191 $ (96,183,720) $ 35,268,769
Balance (in Shares) at Mar. 31, 2026   92,981,204